Quarterly report pursuant to Section 13 or 15(d)

Net Loss Per Share

v3.21.2
Net Loss Per Share
9 Months Ended
Sep. 30, 2021
Net Loss Per Share  
Note 2. Net Loss Per Share

Note 2. Net Loss Per Share

 

Basic net loss per share is computed using the weighted-average number of common shares outstanding during the period except that it does not include unvested common shares subject to repurchase or cancellation. Diluted net income per share is computed using the weighted-average number of common shares and, if dilutive, potential common shares outstanding during the period. Potential common shares consist of the incremental common shares issuable upon the exercise of stock options, warrants and convertible preferred shares (see Note 6. Stockholders’ Equity and Stock-Based Compensation).

 

The treasury stock method is used in calculating diluted EPS for potentially dilutive stock options and share purchase warrants, which assumes that any proceeds received from the exercise of in-the-money stock options and share purchase warrants, would be used to purchase common shares at the average market price for the period, unless including the effects of these potentially dilutive securities would be anti-dilutive.

The following table sets forth the computation of the basic and diluted loss per share:

 

 

 

Three Months Ended

 

 

Nine Months Ended

 

 

 

September 30,

 

 

September 30,

 

 

 

2021

 

 

2020

 

 

2021

 

 

2020

 

Basic

 

 

 

 

 

 

 

 

 

 

 

 

Numerator:

 

 

 

 

 

 

 

 

 

 

 

 

Net loss attributable to common stockholders

 

$ (2,106,660 )

 

$ (3,247,939 )

 

$ (6,109,389 )

 

$ (8,007,891 )

Denominator:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Weighted-average common shares outstanding

 

 

6,759,662

 

 

 

4,053,644

 

 

 

6,648,803

 

 

 

3,613,349

 

Basic net loss per share

 

$ (0.31 )

 

$ (0.80 )

 

$ (0.92 )

 

 

(2.22 )

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Diluted

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Numerator:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Net loss attributable to common stockholders, basic

 

$ (2,106,660 )

 

$ (3,247,939 )

 

$ (6,109,389 )

 

$ (8,007,891 )

Effect of dilutive securities

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

Net loss, diluted

 

$ (2,106,660 )

 

$ (3,247,939 )

 

$ (6,109,389 )

 

$ (8,007,891 )

Denominator:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Weighted average common shares outstanding - basic

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Potential common share issuances:

 

 

6,759,662

 

 

 

4,053,644

 

 

 

6,648,803

 

 

 

3,613,349

 

Incremental dilutive shares from equity instruments (treasury stock method)

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

Weighted-average common shares outstanding

 

 

6,759,662

 

 

 

4,053,644

 

 

 

6,648,803

 

 

 

3,613,349

 

Diluted net loss per share

 

$ (0.31 )

 

$ (0.80 )

 

$ (0.92 )

 

$ (2.22 )

 

The following outstanding securities have been excluded from the computation of diluted weighted shares outstanding for the periods noted below, as they would have been anti-dilutive due to the Company’s losses at September 30, 2021 and 2020 and because the exercise price of certain of these outstanding securities was greater than the average closing price of the Company’s common stock:

 

 

 

At September 30,

 

 

 

2021

 

 

2020

 

Warrants outstanding

 

 

45,577

 

 

 

70,361

 

Stock options outstanding

 

 

568,995

 

 

 

515,985

 

RSUs outstanding

 

 

235,850

 

 

 

-

 

Series A convertible preferred stock to common shares

 

 

79,279

 

 

 

79,297

 

Series B convertible preferred stock to common shares

 

 

286,620

 

 

 

267,405

 

Total

 

 

1,216,321

 

 

 

933,048